Brief: Diagnos Renews Contract With Optina Diagnostics For Alzheimer's Disease Early Detection
02/09/2021 14:16
Sept 2 (Reuters) - Diagnos Inc ADK.V :
* DIAGNOS ANNOUNCES A THREE-YEAR CONTRACT RENEWAL WITH
OPTINA
DIAGNOSTICS PROVIDING A TELEMEDICINE PLATFORM TO SUPPORT THEIR
EARLY DETECTION OF ALZHEIMER’S DISEASE TEST
Source text for Eikon: ID:nGNX3ZblLF
Further company coverage: ADK.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Diagnos
See all newsBrief: Diagnos Submits Modified And Updated Health Canada Licence Application For Cara System Platform
Brief: Diagnos To Submit Future CARA Version To FDA Before End Of Q3
Brief: Diagnos Welcomes Dr. Pierre-Luc Charlebois To Its Advisory Board
Brief: Validated For Global Scale Diagnos Passes Annual MDSAP Audit, Solidifying The Pathway To Approvals With Health Canada & FDA
Brief: Diagnos Provides Update On Its Health Canada Medical Device Licence Application